Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Ischemic heart disease (IHD) market in MEA is impacted by numerous factors. These include lifestyle improvements, health care system reforms, and improved cardiac care. Ischemic heart disease kills and sickens often. Insufficient blood to the cardiac muscle. This affects the MEA's diagnostic, therapeutic, and preventive healthcare needs.
There are changes in the MEA ischemic heart disease market that are caused by population changes, like people living longer and older. The number of people with vascular diseases like IHD rises as the population of the area changes. As the population ages, more people are looking for cures and medicines for ischemic heart disease.
In the MEA area, more and more people are getting ischemic heart disease. This is because people are not moving around as much, eating badly, and gaining weight. Risk factors linked to lifestyle play a big role in how IHD starts and gets worse. This changes the market because it drives the need for treatments and ways to stop it.
How the market works is based on how easy it is to get to places and services for heart care. Building better hospitals, setting up heart-focused medical centers, and making it easier for people to get modern medical equipment all help find and treat ischemic heart disease early. In turn, this changes the need for medical treatments that are related.
Programs that teach people about health and ways to avoid getting IHD change how the market for IHD works in MEA. Ischemic heart disease is less common now that there are public health programs that urge people to change their lifestyle, find the disease early, and take care of their cardiovascular risk factors. People who know more about heart health are more likely to get medical help when they need it and start doing things that are good for their hearts.
The market for heart drugs like antiplatelet agents, statins, and hypertension drugs makes it easy to take care of ischemic heart disease. How easy, cheap, and quick it is to get these medicines influences the market. These medicines help avoid and treat IHD.
If someone has health insurance and heart care costs a lot, it changes how the market works. People with full health insurance are more likely to get checkups, diagnostic tests, and medical treatments for ischemic heart disease. But many people may not be able to get current treatments because they are afraid of the cost.
What programs and rules the government makes about health care really affect the IHD market in MEA? Plans at the national level to lower the number of people who get heart disease, improve healthcare systems, and set up preventative steps can help control and lessen ischemic heart disease.
Research and development of cardiovascular medications affects the market. New medications, sensors, and testing methods being developed to enhance ischemic heart disease care. Market companies research strategies to fulfill patients' medical needs and improve things.
 
MEA Ischemic Heart Disease Market Highlights:
Middle-East and Africa Ischemic Heart Disease Market Overview
Middle-East and Africa Ischemic Heart Disease Market Size was valued at USD 1.90 Billion in 2023. The MEA Ischemic Heart Disease industry is projected to grow from USD 2.30 Billion in 2024 to USD 4.30 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.70% during the forecast period (2024 - 2032).
Ischemic heart disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease.
According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Middle-East and Africa Ischemic heart Disease market is growing steadily.
Study objectives of Middle-East and Africa Ischemic Heart Disease Market:
- To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Middle-East and Africa Ischemic heart disease market
- To provide insights about factors affecting the market growth
- To analyze the Middle-East and Africa Ischemic heart Disease market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Middle East & Africa.
- To provide country level analysis of the market with respect to the current market size and future prospective
- To provide country level analysis of the market for segments by type, by diagnosis, by treatment type and its sub-segments.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Ischemic heart Disease market.
Middle-East and Africa Ischemic Heart Disease Market Segments
Middle-East and Africa Ischemic heart Disease market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others.
On the basis of diagnosis the market is segmented into (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others.
On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others.
Key Players for Middle-East and Africa Ischemic Heart Disease Market
Some of the key players in this market are:
- King Faisal Specialist Hospital and Research Centre (Saudi Arabia)
- Riyadh Military Hospital (Saudi Arabia)
- Hamad Medical Corporation (Qatar)
- American Hospital Dubai
- Ganzouri Specialized Hospital (Egypt)
- AstraZeneca (U.K.)
- Sanofi (France)
- Merck Sharp & Dohme Corp.(U.S.)
- AUM Cardiovascular (US)
- HeartWare (U.S.)
Intended Audience:
- Middle-East and Africa Ischemic heart disease Equipment manufacturers
- Middle-East and Africa Ischemic heart disease Equipment Suppliers
- Government and Independent Regulatory Authorities
- Research and Development (R&D) Companies
- Independent Research Laboratories
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Regional Analysis of Middle-East and Africa Ischemic heart Disease Market
Considering the Middle-East and Africa Ischemic heart Disease Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Ischemic heart Disease. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart Disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.
The report for Middle-East and Africa Ischemic heart Disease market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
